PIK3CA and cancer: As such, we specifically introduce oncogenic activation of the PI3K pathway (mutation of PIK3CA, the p110α catalytic subunit of PI3K, frequently mutated in a number of different human cancers, including those of the breast23, 24, 25) in mammary epithelial cells interacting with complex physical cues.